Dan,
Thanks for taking the time to reply and for offering encouragement to others, long after your own successful treatment.
It is a shame to see so many interesting threads about success stories suddenly stop, in some of the forums I have visited.
I assume that after a successful SCT the patient wants to put the experience behind them, when they could be of so much help to those who are about to go through the experience.
Best Regards
David
__________________
David, Age 60, diagnosed with MDS August 2018. Low Hb and platelets, weekly transfusions. No genetic mutations. Developed into AML with FLT3 mutation while waiting for a SCT. Allogenic SCT - MUD in Feb 2019. Relapsed June 2019. Azacitidine, Venetoclax and DLI.
|